Finally, the association of the immune microenvironment with cancer outcomes is increasingly uncovered.45,46 Similarly, there is increasing evidence that mesenchymal cancer cells can modulate the immune infiltrate to promote tumor progression.47 Investigating the interdependence of immune scores and ZEB2 expression was beyond the scope of the current study; however, this may be critical in future efforts. The gene discussed is ZEB2; the disease is cancer.